Market Price

47.44 

-0.31 -0.7%

as of Oct 21 '20

52 Week Range:

34.21 63.23


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it sells hardware products, such as bone and joint fixation, and joint replacement devices; and implants and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Princeton, New Jersey.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 7.78
8.76
9.35
9.26
7.77
10.48
9.88
11.02
11.65
16.02
16.13
growth rate 12.6% 6.7% -1.0% -16.1% 34.9% -5.7% 11.5% 5.7% 37.5% 0.7%
Earnings BIT 73.15
82.11
28.49
52.03
-24.79
125.81
136.73
159.06
180.58
235.91
260.99
growth rate 12.3% -65.3% 82.6% -100.0% 100.0% 8.7% 16.3% 13.5% 30.6% 10.6%
Avg.PE 21.19
21.74
32.47
26.95
-130.21
57.43
49.07
55.12
86.25
52.42
84.82
growth rate 2.6% 49.4% -17.0% -100.0% 100.0% -14.6% 12.3% 56.5% -39.2% 61.8%
ROA 5.16
6.71
2.59
3.57
-1.44
2.45
-0.21
4.16
2.58
1.92
1.57
growth rate 30.0% -61.4% 37.8% -100.0% 100.0% -100.0% 100.0% -38.0% -25.6% -18.2%
ROE 12.82
13.90
5.64
8.16
-2.86
4.95
-0.48
9.37
7.19
5.20
3.60
growth rate 8.4% -59.4% 44.7% -100.0% 100.0% -100.0% 100.0% -23.3% -27.7% -30.8%
ROIC 7.53
9.25
6.01
5.61
-0.35
4.27
0.76
6.48
3.92
3.83
3.08
growth rate 22.8% -35.0% -6.7% -100.0% 100.0% -82.2% 752.6% -39.5% -2.3% -19.6%
Cur. Ratio 2.33
2.22
4.44
4.24
4.40
4.20
3.15
4.01
2.36
2.95
2.59
growth rate -4.7% 100.0% -4.5% 3.8% -4.6% -25.0% 27.3% -41.2% 25.0% -12.2%
Quick Ratio 1.12
1.17
2.15
1.98
2.00
1.62
1.30
2.02
1.22
1.54
1.43
growth rate 4.5% 83.8% -7.9% 1.0% -19.0% -19.8% 55.4% -39.6% 26.2% -7.1%
Leverage 2.11
2.03
2.32
2.25
1.78
2.24
2.36
2.15
3.34
2.25
2.33
growth rate -3.8% 14.3% -3.0% -20.9% 25.8% 5.4% -8.9% 55.4% -32.6% 3.6%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 103.20
106.00
154.28
154.02
166.76
110.41
132.24
148.19
251.80
265.74
283.98
growth rate 2.7% 45.6% -0.2% 8.3% -33.8% 19.8% 12.1% 69.9% 5.5% 6.9%
Acct.Payable 97.33
103.42
115.19
28.87
34.77
29.06
93.97
76.05
113.09
growth rate 6.3% 11.4% -74.9% 20.5% -16.4% 223.4% -19.1% 48.7%
Cur.Assets 365.40
444.80
452.26
453.05
521.15
529.32
438.50
495.17
822.15
775.08
858.17
growth rate 21.7% 1.7% 0.2% 15.0% 1.6% -17.2% 12.9% 66.0% -5.7% 10.7%
Total Assets 940.10
1,017.30
1,144.11
1,163.60
1,192.14
1,587.42
1,774.22
1,807.95
3,211.26
3,107.89
3,303.24
growth rate 8.2% 12.5% 1.7% 2.5% 33.2% 11.8% 1.9% 77.6% -3.2% 6.3%
Cash 71.90
128.80
100.81
96.94
120.61
71.73
48.13
102.06
174.94
138.84
198.91
growth rate 79.1% -21.7% -3.8% 24.4% -40.5% -32.9% 112.0% 71.4% -20.6% 43.3%
Inventory 140.20
146.90
171.26
171.81
206.92
189.13
211.43
217.26
296.33
280.35
316.05
growth rate 4.8% 16.6% 0.3% 20.4% -8.6% 11.8% 2.8% 36.4% -5.4% 12.7%
Cur.Liabilities 156.70
200.00
101.87
106.93
119.38
126.03
139.13
123.60
348.91
262.55
331.31
growth rate 27.6% -49.1% 5.0% 11.7% 5.6% 10.4% -11.2% 182.3% -24.8% 26.2%
Liabilities 495.20
517.30
651.47
645.82
526.05
883.10
1,022.78
968.29
2,248.95
1,732.09
1,886.50
growth rate 4.5% 25.9% -0.9% -18.6% 67.9% 15.8% -5.3% 132.3% -23.0% 8.9%
LT Debt 308.80
294.80
532.26
519.55
392.06
626.25
700.12
665.00
1,782.72
1,341.10
1,341.58
growth rate -4.5% 80.6% -2.4% -24.5% 59.7% 11.8% -5.0% 168.1% -24.8% 0.0%
Equity 444.90
500.00
492.64
517.78
666.09
704.32
751.44
839.67
962.31
1,375.80
1,416.74
growth rate 12.4% -1.5% 5.1% 28.6% 5.7% 6.7% 11.7% 14.6% 43.0% 3.0%
Common Shares 59.00
60.00
59.00
57.00
58.00
66.00
71.00
79.00
79.00
84.00
86.00
growth rate 1.7% -1.7% -3.4% 1.8% 13.8% 7.6% 11.3% 0.0% 6.3% 2.4%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 25.20
37.10
38.43
69.03
42.30
38.34
33.41
47.33
43.50
77.74
69.54
growth rate 47.2% 3.6% 79.7% -38.7% -9.4% -12.9% 41.7% -8.1% 78.7% -10.6%
Cash Dividends 0.00
0.00
0.00
0.00
47.01
47.01
growth rate 0.0%
Cash From OA 143.20
105.60
104.33
59.10
53.27
83.57
104.85
116.41
114.54
199.68
231.43
growth rate -26.3% -1.2% -43.4% -9.9% 56.9% 25.5% 11.0% -1.6% 74.3% 15.9%
FCF per Share 1.97
1.13
0.91
-0.18
-0.44
0.47
0.81
1.07
0.74
1.25
0.54
growth rate -42.6% -19.5% -100.0% 0.0% 100.0% 72.3% 32.1% -30.8% 68.9% -56.8%
Sale Purchase of Stock -51.32
0.70
154.80
15.22
227.01
10.48
9.77
growth rate 100.0% 22,141.7% -90.2% 1,392.0% -95.4% -6.8%
FCF 116.00
68.00
66.00
-10.00
5.00
37.00
61.00
69.00
71.00
122.00
97.00
growth rate -41.4% -2.9% -100.0% 100.0% 640.0% 64.9% 13.1% 2.9% 71.8% -20.5%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 682.50
732.10
780.08
830.87
696.83
796.72
882.73
992.08
1,188.24
1,472.44
1,517.56
growth rate 7.3% 6.6% 6.5% -16.1% 14.3% 10.8% 12.4% 19.8% 23.9% 3.1%
Op.Income 97.80
98.70
27.99
41.20
22.03
125.81
136.73
159.06
180.58
235.91
260.99
growth rate 0.9% -71.6% 47.2% -46.5% 471.2% 8.7% 16.3% 13.5% 30.6% 10.6%
IBT 73.20
82.10
28.49
52.03
18.79
45.57
60.67
90.41
11.39
57.40
60.10
growth rate 12.2% -65.3% 82.6% -63.9% 142.6% 33.2% 49.0% -87.4% 404.2% 4.7%
Net Income 51.00
65.70
27.99
41.20
22.03
34.00
-3.52
74.56
64.74
60.80
50.20
growth rate 28.8% -57.4% 47.2% -46.5% 54.4% -100.0% 100.0% -13.2% -6.1% -17.4%
EPS 0.87
1.08
0.47
0.72
-0.37
0.52
-0.05
0.94
0.82
0.72
0.58
growth rate 24.1% -56.5% 53.2% -100.0% 100.0% -100.0% 100.0% -12.8% -12.2% -19.4%
Gross Profit 437.60
463.90
480.93
516.44
417.28
510.87
573.61
661.86
781.14
935.51
978.14
growth rate 6.0% 3.7% 7.4% -19.2% 22.4% 12.3% 15.4% 18.0% 19.8% 4.6%
R&D 44.30
48.10
51.45
51.01
42.62
43.06
49.94
57.96
63.46
78.04
75.68
growth rate 8.6% 7.0% -0.9% -16.5% 1.0% 16.0% 16.1% 9.5% 23.0% -3.0%

Quarterly Statements

Item Name Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Earnings BIT 70.35
63.93
66.99
45.69
22.27
growth rate -9.1% 4.8% -31.8% -51.3%
Balance Sheet Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Acct.Receivable 304.69
290.49
283.98
253.49
186.55
growth rate -4.7% -2.2% -10.7% -26.4%
Acct.Payable 107.19
94.16
113.09
97.06
58.29
growth rate -12.2% 20.1% -14.2% -39.9%
Cur.Assets 868.67
883.81
858.17
1,008.67
966.22
growth rate 1.7% -2.9% 17.5% -4.2%
Total Assets 3,290.41
3,346.58
3,303.24
3,447.57
3,391.76
growth rate 1.7% -1.3% 4.4% -1.6%
Cash 176.08
207.98
198.91
357.71
360.98
growth rate 18.1% -4.4% 79.8% 0.9%
Inventory 296.51
302.62
316.05
338.08
358.76
growth rate 2.1% 4.4% 7.0% 6.1%
Cur.Liabilities 315.11
302.64
331.31
246.49
212.42
growth rate -4.0% 9.5% -25.6% -13.8%
Liabilities 1,869.46
1,961.61
1,886.50
2,105.76
2,042.66
growth rate 4.9% -3.8% 11.6% -3.0%
LT Debt 1,347.35
1,435.93
1,341.58
1,652.65
1,620.45
growth rate 6.6% -6.6% 23.2% -2.0%
Equity 1,420.95
1,384.97
1,416.74
1,341.80
1,349.10
growth rate -2.5% 2.3% -5.3% 0.5%
Common Shares 0.88
0.89
0.89
0.89
0.89
growth rate 0.3% 0.1% 0.2% 0.3%
Cash Flow Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Capital Expenditures 17.66
13.59
22.19
16.52
7.22
growth rate -23.1% 63.3% -25.6% -56.3%
Cash Dividends
growth rate
Cash From OA 48.52
64.24
89.18
20.81
33.12
growth rate 32.4% 38.8% -76.7% 59.1%
Sale Purchase of Stock
growth rate
FCF 30.86
50.65
66.99
4.30
25.90
growth rate 64.1% 32.3% -93.6% 503.0%
Income Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Sales 383.65
379.10
395.13
354.32
258.67
growth rate -1.2% 4.2% -10.3% -27.0%
Op.Income 70.35
63.93
66.99
45.69
22.27
growth rate -9.1% 4.8% -31.8% -51.3%
IBT 36.38
-27.51
26.41
11.44
1.65
growth rate -100.0% 100.0% -56.7% -85.6%
Net Income 29.74
-27.61
15.32
9.18
-0.37
growth rate -100.0% 100.0% -40.1% -100.0%
EPS
growth rate
Gross Profit 247.31
242.42
253.75
230.16
159.49
growth rate -2.0% 4.7% -9.3% -30.7%
R&D 17.63
19.00
22.40
21.87
14.30
growth rate 7.8% 17.9% -2.4% -34.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (54.30)

YOY Growth Grade:

D (33.79)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 154.63 -1,157.07 16.66
EPS / Growth 13.8% -0.04 6.9%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 14.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.9% 11.7% 11.7%
Future PE 13.84 20.01 20.01
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.